Seroprevalence of SARS COV-2 anti-nucleocapsid antibodies in Turkish healthcare workers before vaccination schedule: January 2021

Seroprevalence of SARS COV-2 anti-nucleocapsid antibodies in Turkish healthcare workers before vaccination schedule: January 2021

Objective: We aimed to assess the seroprevalence of SARS-CoV-2 infection and associated factors among Turkish HCWs, before the Covid-19 vaccination program in January 2021. Material and methods: We performed antibody assessment against SARS-CoV-2 in blood samples from participants using the Elecsys®...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:"Qazaqstannyn͡g︡ klinikalyq medit͡s︡inasy" zhurnaly 2022-06, Vol.19 (3), p.65-68
Hauptverfasser: Kılınç Toker, Ayşin, Turunç Özdemir, Ayşe, Çerçioğlu Özdemir, Duygu, Eryilmaz Eren, Esma, Saatçi, Esma, Toker, İbrahim, Çelik, İlhami
Format: Artikel
Sprache:eng
Schlagworte:
COVID-19
healthcare worker
SARS-CoV-2 antibody
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: We aimed to assess the seroprevalence of SARS-CoV-2 infection and associated factors among Turkish HCWs, before the Covid-19 vaccination program in January 2021. Material and methods: We performed antibody assessment against SARS-CoV-2 in blood samples from participants using the Elecsys® Anti-SARS-CoV-2 electrochemiluminescence immunoassay. Samples with a cut-off index (COI; signal sample/cut-off)
ISSN:1812-2892
2313-1519
DOI:10.23950/jcmk/12150